Developing a MLC modifier program to improve fiducial detection for MV/kV imaging during hypofractionated prostate volumetric modulated arc therapy

被引:12
|
作者
Happersett, Laura [1 ]
Wang, Ping [1 ]
Zhang, Pengpeng [1 ]
Mechalakos, James [1 ]
Li, Guang [1 ]
Eley, Eleanor [1 ]
Zelefsky, Michael [1 ]
Mageras, Gig [1 ]
Damato, Antonio L. [1 ]
Hunt, Margie [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源
关键词
fiducial tracking; image-guided radiotherapy; motion management; MV; kV imaging; prostate;
D O I
10.1002/acm2.12614
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose To develop an Eclipse plug-in (MLC_MODIFIER) that automatically modifies control points to expose fiducials obscured by MLC during VMAT, thereby facilitating tracking using periodic MV/kV imaging. Method Three-dimensional fiducial tracking was performed during VMAT by pairing short-arc (3 degrees) MV digital tomosynthesis (DTS) images to triggered kV images. To evaluate MLC_MODIFIER efficacy, two cohorts of patients were considered. For first 12 patients, plans were manually edited to expose one fiducial marker. Next for 15 patients, plans were modified using MLC_MODIFIER script. MLC_MODIFIER evaluated MLC apertures at appropriate angles for marker visibility. Angles subtended by control points were compressed and low-dose "imaging" control points were inserted and exposed one marker with 1 cm margin. Patient's images were retrospectively reviewed to determine rate of MV registration failures. Failure categories were poor DTS image quality, MLC blockage of fiducials, or unknown reasons. Dosimetric differences in rectum, bladder, and urethra D1 cc, PTV maximum dose, and PTV dose homogeneity (PTV HI) were evaluated. Statistical significance was evaluated using Fisher's exact and Student's t test. Result Overall MV registration failures, failures due to poor image quality, MLC blockage, and unknown reasons were 33% versus 8.9% (P < 0.0001), 8% versus 6.4% (P < 0.05), 13.6% versus 0.1% (P < 0.0001), and 7.6% versus 2.4% (P < 0.0001) for manually edited and MLC_MODIFIER plans, respectively. PTV maximum and HI increased on average from unmodified plans by 2.1% and 0.3% (P < 0.004) and 22.0% and 3.3% (P < 0.004) for manually edited and MLC_MODIFIED plans, respectively. Changes in bladder, rectum, and urethra D1CC were similar for each method and less than 0.7%. Conclusion Increasing fiducial visibility via an automated process comprised of angular compression of control points and insertion of additional "imaging" control points is feasible. Degradation of plan quality is minimal. Fiducial detection and registration success rates are significantly improved compared to manually edited apertures.
引用
收藏
页码:120 / 124
页数:5
相关论文
共 50 条
  • [1] Developing a MLC-Modifier Program for MV/kV Imaging During Hypofractionated Prostate Volumetric Modulated Arc Therapy
    Happersett, L.
    Wang, P.
    Zhang, P.
    Mechalakos, J.
    Pham, H.
    Li, G.
    Zelefsky, M.
    Mageras, G.
    Hunt, M.
    [J]. MEDICAL PHYSICS, 2017, 44 (06) : 2984 - 2985
  • [2] Optimized Hybrid MV-kV Imaging Protocol for Volumetric Prostate Arc Therapy
    Liu, W.
    Luxton, G.
    Xing, L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S570 - S571
  • [3] Simultaneous MV-kV imaging for intrafractional motion management during volumetric-modulated arc therapy delivery
    Hunt, Margie A.
    Sonnick, Mark
    Pham, Hai
    Regmi, Rajesh
    Xiong, Jian-ping
    Morf, Daniel
    Mageras, Gig S.
    Zelefsky, Michael
    Zhang, Pengpeng
    [J]. JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2016, 17 (02): : 473 - 486
  • [4] Optimizing fiducial visibility on periodically acquired megavoltage and kilovoltage image pairs during prostate volumetric modulated arc therapy
    Zhang, Pengpeng
    Happersett, Laura
    Ravindranath, Bosky
    Zelefsky, Michael
    Mageras, Gig
    Hunt, Margie
    [J]. MEDICAL PHYSICS, 2016, 43 (05) : 2024 - 2029
  • [5] 4D-CBCT reconstruction using MV portal imaging during volumetric modulated arc therapy
    Kida, Satoshi
    Saotome, Naoya
    Masutani, Yoshitaka
    Yamashita, Hideomi
    Ohtomo, Kuni
    Nakagawa, Keiichi
    Sakumi, Akira
    Haga, Akihiro
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 100 (03) : 380 - 385
  • [6] 4D-CT RECONSTRUCTION USING MV PORTAL IMAGING DURING VOLUMETRIC MODULATED ARC THERAPY
    Kida, S.
    Saotome, N.
    Haga, A.
    Masutani, Y.
    Yamashita, H.
    Sakumi, A.
    Ohtomo, K.
    Keiichi, N.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S95 - S96
  • [7] MV-kV Intrafractional Imaging During Volume Modulated Arc Therapy (VMAT): Initial Clinical Results
    Hunt, M. A.
    Regmi, R.
    Zhang, P.
    Mageras, G.
    Zelefsky, M.
    Morf, D.
    Cox, B.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S217 - S217
  • [8] Evolution of QA program for dynamic MLC in volumetric modulated arc therapy based on EPID portal dosimetry
    Tortosa Oliver, R.
    Chinillach Ferrando, N.
    Soler Catalan, P.
    Morales Marco, J. C.
    Andreu Martinez, F.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S258 - S258
  • [9] Pelvic Volumetric Modulated Arc Therapy With Hypofractionated Concomitant Integrated Prostate Boost: An Isoeffective Dose Comparison
    Tsvang, L.
    Alezra, D.
    Pfeffer, R.
    Symon, Z.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S396 - S396
  • [10] Pelvic Volumetric Modulated Arc Therapy with Hypofractionated Concomitant Integrated Prostate Boost: An Isoeffective Dose Comparison
    Tsvang, Lev
    Pfeffer, Raphael
    Symon, Zvi
    [J]. MEDICAL PHYSICS, 2012, 39 (06) : 3843 - 3843